Cellebrite DI (CLBT) EBT (2020 - 2025)

Cellebrite DI's EBT history runs 6 years deep, the most recent figure standing at $26.3 million for Q4 2025.

• In Q4 2025, EBT rose 32.03% year-over-year to $26.3 million; the TTM figure through Dec 2025 stood at $90.7 million (up 132.86% YoY), while the FY2025 annual figure was $90.7 million, up 132.86% from the prior year.
• EBT was $26.3 million for Q4 2025 at Cellebrite DI, up from $24.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of $54.5 million in Q1 2022 to a low of -$204.5 million in Q3 2024.
• Historically, EBT has averaged -$2.9 million across 5 years, with a median of $11.9 million in 2021.
• The sharpest annual moves came in 2022 and 2024: EBT jumped 1141.26% in 2022, then sank 3086.38% in 2024.
• A 5-year view of EBT shows it stood at $54.1 million in 2021, then slumped by 83.18% to $9.1 million in 2022, then slumped by 235.63% to -$12.3 million in 2023, then soared by 261.17% to $19.9 million in 2024, then soared by 32.03% to $26.3 million in 2025.
• The last three EBT figures came in at $26.3 million (Q4 2025), $24.3 million (Q3 2025), and $20.8 million (Q2 2025), per Business Quant data.